Shanghai Roche announces Avastin OK in China

Joint venture Shanghai Roche Pharma has announced Chinese approval for cancer treatment Avastin. The announcement follows by a week the news of an Avastin fake used as a treatment for eye disease causing adverse reactions in more than half of those given the knockoff. Article

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.